Eiger Biopharmaceuticals (NASDAQ:EIGR) Insider Buying and Selling Activity
Insider Ownership Percentage: 5.80%
Eiger Biopharmaceuticals (NASDAQ EIGR) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/22/2019 | Sriram Ryali | CFO | Buy | 1,250 | $11.08 | $13,850.00 | 1,250 |  |
| 4/22/2019 | Stephana Eilene Patton | Insider | Buy | 1,000 | $11.03 | $11,030.00 | 4,000 | |
| 4/22/2019 | Thomas John Dietz | Director | Buy | 5,000 | $11.05 | $55,250.00 | 15,000 | |
| 2/4/2019 | David A Cory | Insider | Buy | 227 | $14.13 | $3,207.51 | 58,678 | |
| 12/20/2018 | Thomas John Dietz | Director | Buy | 5,000 | $9.98 | $49,900.00 | 10,000 | |
| 12/6/2018 | Thomas John Dietz | Director | Buy | 5,000 | $11.26 | $56,300.00 | 5,000 | |
| 11/28/2018 | Eldon C Mayer III | Director | Buy | 6,000 | $10.07 | $60,420.00 | 7,500 | |
| 11/26/2018 | Eldon C Mayer III | Director | Buy | 7,500 | $9.75 | $73,125.00 | 7,500 | |
| 10/18/2018 | Interwest Partners X. Lp | Major Shareholder | Sell | 237,265 | $12.06 | $2,861,415.90 | | |
| 4/2/2018 | Joanne Quan | Insider | Sell | 4,000 | $10.00 | $40,000.00 | 4,000 | |
| 9/1/2017 | Jeffrey S Glenn | Director | Buy | 15,000 | $9.53 | $142,950.00 | 31,355 | |
| 11/18/2016 | Jeffrey S Glenn | Director | Buy | 15,460 | $12.74 | $196,960.40 | 16,355 | |
| 8/18/2016 | James P Shaffer | Insider | Buy | 3,125 | $15.70 | $49,062.50 | 5,620 | |
| 8/18/2016 | Ventures Fund Vi L.P. Vivo | Major Shareholder | Buy | 187,500 | $16.00 | $3,000,000.00 | | |
| 6/22/2016 | James H Welch | CFO | Buy | 2,500 | $19.80 | $49,500.00 | 2,000 | |
| 6/13/2016 | James P Shaffer | Insider | Buy | 1,250 | $22.17 | $27,712.50 | 1,975 | |
| 5/23/2016 | James P Shaffer | Insider | Buy | 1,245 | $19.80 | $24,651.00 | 500 | |
| 4/6/2015 | Krisztina M Zsebo | CEO | Sell | 47,931 | $18.20 | $872,344.20 | | |
| 4/2/2015 | Rebecque J Laba | VP | Sell | 11,012 | $17.30 | $190,507.60 | | |
| 3/9/2015 | Krisztina M Zsebo | CEO | Sell | 47,931 | $24.80 | $1,188,688.80 | | |
| 3/6/2015 | Peter Honig | Director | Sell | 9,700 | $23.74 | $230,278.00 | | |
| 3/6/2015 | Rebecque J Laba | VP | Sell | 14,000 | $23.06 | $322,840.00 | | |
| 3/2/2015 | Ryan K Takeya | VP | Sell | 7,777 | $18.48 | $143,718.96 | | |
| 2/9/2015 | Krisztina M Zsebo | CEO | Sell | 47,931 | $15.86 | $760,185.66 | | |
| 2/6/2015 | Rebecque J Laba | VP | Sell | 14,000 | $16.08 | $225,120.00 | | |
| 2/2/2015 | Ryan K Takeya | VP | Sell | 7,777 | $16.35 | $127,153.95 | | |
| 1/9/2015 | Jeffrey J Rudy | VP | Sell | 10,000 | $18.51 | $185,100.00 | | |
| 1/7/2015 | Rebecque J Laba | VP | Sell | 20,000 | $17.30 | $346,000.00 | | |
| 1/6/2015 | Krisztina M Zsebo | CEO | Sell | 41,302 | $17.51 | $723,198.02 | | |
| 1/2/2015 | Ryan K Takeya | VP | Sell | 7,777 | $19.88 | $154,606.76 | | |
| 12/9/2014 | Jeffrey J Rudy | VP | Sell | 10,000 | $15.00 | $150,000.00 | | |
| 12/9/2014 | Krisztina M Zsebo | CEO | Sell | 41,302 | $15.00 | $619,530.00 | | |
| 12/5/2014 | Rebecque J Laba | VP | Sell | 20,000 | $12.77 | $255,400.00 | | |
| 12/1/2014 | Ryan K Takeya | VP | Sell | 7,777 | $12.01 | $93,401.77 | | |
| 2/4/2014 | Enterprise Partners Management | Major Shareholder | Buy | 133,083 | $8.00 | $1,064,664.00 | | |
| 2/4/2014 | Fredrik Wiklund | VP | Buy | 20,000 | $8.00 | $160,000.00 | | |
| 2/4/2014 | Todd Foley | Director | Buy | 111,608 | $8.00 | $892,864.00 | | |
(Data available from 1/1/2013 forward)
